1. Home
  2. TECX vs JMSB Comparison

TECX vs JMSB Comparison

Compare TECX & JMSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECX
  • JMSB
  • Stock Information
  • Founded
  • TECX 2019
  • JMSB 2005
  • Country
  • TECX United States
  • JMSB United States
  • Employees
  • TECX N/A
  • JMSB 133
  • Industry
  • TECX
  • JMSB Major Banks
  • Sector
  • TECX
  • JMSB Finance
  • Exchange
  • TECX Nasdaq
  • JMSB Nasdaq
  • Market Cap
  • TECX 334.4M
  • JMSB 250.6M
  • IPO Year
  • TECX 2018
  • JMSB N/A
  • Fundamental
  • Price
  • TECX $21.51
  • JMSB $17.44
  • Analyst Decision
  • TECX Buy
  • JMSB
  • Analyst Count
  • TECX 6
  • JMSB 0
  • Target Price
  • TECX $79.20
  • JMSB N/A
  • AVG Volume (30 Days)
  • TECX 172.8K
  • JMSB 16.4K
  • Earning Date
  • TECX 05-08-2025
  • JMSB 07-23-2025
  • Dividend Yield
  • TECX N/A
  • JMSB 2.87%
  • EPS Growth
  • TECX N/A
  • JMSB 475.76
  • EPS
  • TECX N/A
  • JMSB 1.24
  • Revenue
  • TECX N/A
  • JMSB $54,782,000.00
  • Revenue This Year
  • TECX N/A
  • JMSB N/A
  • Revenue Next Year
  • TECX N/A
  • JMSB N/A
  • P/E Ratio
  • TECX N/A
  • JMSB $14.07
  • Revenue Growth
  • TECX N/A
  • JMSB 50.81
  • 52 Week Low
  • TECX $13.70
  • JMSB $13.81
  • 52 Week High
  • TECX $61.07
  • JMSB $26.52
  • Technical
  • Relative Strength Index (RSI)
  • TECX 51.42
  • JMSB 56.02
  • Support Level
  • TECX $21.20
  • JMSB $17.01
  • Resistance Level
  • TECX $22.75
  • JMSB $17.68
  • Average True Range (ATR)
  • TECX 1.43
  • JMSB 0.42
  • MACD
  • TECX 0.01
  • JMSB -0.05
  • Stochastic Oscillator
  • TECX 41.32
  • JMSB 40.76

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About JMSB John Marshall Bancorp Inc.

John Marshall Bancorp Inc is a bank holding company. Through its banking subsidiary, it offers banking products and financial services to small to medium-sized businesses, professional corporations, non-profits, and individuals. The products and services offered by the company include commercial checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential and commercial construction and development loans, online banking, and mobile banking. The firm serves local businesses, professionals, individuals, and families throughout the Washington, D.C. metropolitan area.

Share on Social Networks: